TheESH 9th Ttranslational Research Conference on MDS proposes a programme of leading-edge basic and clinical science, as well as opportunities for informal scientific interaction with a panel of global experts in the field. It is open to an international audience of biologists and clinicians, including those still in training. Chairs: Pierre Fenaux, Katharina Götze, Mikkael Sekeres

Date: Friday 12 - Sunday 14 April 2024
Venue: Budapest Marriott Hotel, Budapest

This translational research conference will bring together biologists and clinicians with an interest in Myelodysplastic Syndromes (MDS) in order to explore the most recent advances in the understanding of the pathogenesis and clinical behavior of the disease. New data will be presented on how to best apply these insights to the future of MDS therapy. Diagnostic, prognostic and therapeutic issues will be presented by the faculty and ample time will be devoted to discussion with delegates.

This conference is accredited by the European Board for Accreditation in Hematology (EBAH) CME system. Participants will be eligible to claim CME credit points.

Posters and Brief Oral Communications
Registered participants are invited to submit their abstracts. Selected abstracts are eligible for an oral or a poster presentation. Call for abstracts: deadline 15 January 2024.

The meeting will be of interest to:

  • Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
  • Junior scientists and clinicians (MD, PhD)
  • PhD candidates and clinical residents still in training

Learning Objectives
Upon completion of this CME activity, participants should be able to:

  • Learn how to optimally diagnose MDS, mainly by morphological analysis and cytogenetics, but also through the use of new tools, mainly molecular analysis.
  • Improve ability to analyse prognostic factors, including new ones (revised IPSS, molecular analysis).
  • Review current treatment of MDS, in both the high risk and low risk settings, ranging from single follow up to allogeneic stem cell transplantation.
  • Acquire improved knowledge of emerging treatments, based on targeted therapies and well conducted clinical trials.
  • Scientific Topics
    The sinister origins of MDS
  • The interplay between MDS, inflammatory, and immune abnormalities
  • What's in a name? Classifying MDS
  • New tools to explore MDS
  • Special populations
  • Treatment of lower-risk MDS
  • Treatment of higher-risk MDS
  • Transplantation
  • Clinical trials in MDS/CMML: cooperative groups

The program will include:

  • Plenary Sessions
  • Panel Discussions
  • Simultaneous Meet the Expert Sessions
  • Poster Walks
  • Brief Oral Communications

For further information and to register for the event please visit the conference website

External Events

Jan 25
13
14
20
21
23
26
27
29
Feb 25
5
11
Mar 25
7
13
18
26
27
January 13th 2025
A CLL refresher with gems from ASH24 - A comple...
A CLL refresher with gems from ASH24 **6 CPD points requested for full course The Complete Evening Training Cou...
Details
January 14th 2025
Recent Advances in Haematology 2025, including...
Join us for a day of comprehensive interactive talks from our expert Haematology faculty, including highlights from A...
Location: King's College Hospital
Details
January 20th 2025
A CLL refresher with gems from ASH24 - A comple...
A CLL refresher with gems from ASH24 **6 CPD points requested for full course The Complete Evening Training Cou...
Details
January 21st 2025
Post ASH Significant Highlights (4)
This meeting will provide an overview of the most innovative scientific and clinical data presented at ASH 2024 Suit...
Location: Royal College of Physicians
Details
January 23rd 2025
Haematological Malignancy Diagnostic Service (H...
Welcome to the King’s Health Partners Haematology Haematological Malignancy Diagnostic Service (HDMS) Integrated Diag...
Location: King's College Hospital
Details
January 26th 2025
UCLH Challenges in MPN:An MDT approach
A clinically-orientated and interactive day, focusing on management of difficult MPN cases, new diagnostic tests/tech...
Details
January 27th 2025
A CLL refresher with gems from ASH24 - A comple...
27 January 2024 7 pm-9 pm Design and conduit of clinical trials in the UK. Dr Talha Munir MDM discussions: u...
Details
January 29th 2025
Post ASH and What's New in Haematological Malig...
This meeting will provide an overview of the most innovative scientific and clinical data presented at ASH 2024 that...
Location: Doubletree by Hilton City Centre
Details
February 5th 2025
South West Lymphoma Group (5)
This meeting will provide South West delegates with a useful opportunity to share latest data, best practice and keep...
Details
February 11th 2025
Post ISTH & ASH Headlines 2025
This national Non-Malignant Haematology Evidence Update meeting will include sessions covering relevant topics in thr...
Details
March 7th 2025
UK CLL Forum Annual Scientific Day (5)
This meeting will be held as a face-to-face event to facilitate collaboration and networking, alongside the education...
Location: Cavendish Conference Centre
Details
March 13th 2025
UK North Myeloma Forum (2)
The UK North Myeloma Forum aims to bring together clinicians and AHPs working in Myeloma to disseminate national and...
Details
March 18th 2025
What's New in Haematological Malignancies (2)
A leading expert faculty will deliver a day of lectures and discussions to explore “What’s New in Haematological Mali...
Details
March 26th 2025
East Midlands Myeloid Update Day
This regional update day will focus on interesting developments in AML, MPNs and CML. Suitable for Consultants, Tr...
Details
March 27th 2025
East Midlands Lymphoma Forum
This meeting will provide East Midlands delegates with a useful opportunity to share latest data, best practice and k...
Details